Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer (ACBC) reduced the side effects associated with cognitive impairment. We evaluated the effects of melatonin on cognition...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Ana Claudia Souza, Zortea, Maxciel, Souza, Andressa, Santos, Vinicius, Biazús, Jorge Villanova, Torres, Iraci L. S., Fregni, Felipe, Caumo, Wolnei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164654/
https://www.ncbi.nlm.nih.gov/pubmed/32302347
http://dx.doi.org/10.1371/journal.pone.0231379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164654/
https://www.ncbi.nlm.nih.gov/pubmed/32302347
http://dx.doi.org/10.1371/journal.pone.0231379

Ejemplares similares